BioZorb Breast Tissue Marker

More Than 200 Women File BioZorb Lawsuits Over Breast Tissue Marker Complications

Over 200 women have filed lawsuits alleging that the BioZorb surgical marker, used in breast cancer procedures, caused painful complications after implantation. Plaintiffs claim the device can migrate, become infected, or require additional surgeries for removal. The growing number of cases has led to increased scrutiny of how the device was marketed and cleared for use.

https://www.aboutlawsuits.com/biozorb-lawsuit/200-women-biozorb-lawsuits-complications-breast-tissue-marker

First BioZorb Marker Trial Set for January 2026

The first bellwether trial in the BioZorb breast tissue marker litigation has been scheduled for January 2026. This case will serve as a test for how juries respond to allegations that the device caused severe complications. The outcome may influence settlement negotiations for hundreds of pending claims nationwide.

https://www.aboutlawsuits.com/biozorb-lawsuit/biozorb-marker-lawsuit-trial-january-2026/

AFFF / PFAS

Unfiled AFFF Lawsuits Must Be Submitted or Face Restrictions

The court overseeing the AFFF firefighting foam litigation has ordered lawyers to submit all unfiled claims or risk losing the ability to include them in future settlement talks. The directive is intended to create an accurate census of claims related to PFAS-related cancers and water contamination. Attorneys warn that failure to comply could significantly impact recovery for affected plaintiffs.

https://www.aboutlawsuits.com/afff/affff-lawsuit-lawyers-must-submit-unfiled-claims-or-face-restrictions/

Firefighter Gear Lawsuits To Be Consolidated With AFFF Cases

Lawsuits alleging toxic PFAS exposure from firefighter turnout gear will be consolidated into the same multidistrict litigation as firefighting foam cases. Plaintiffs argue that the gear contained dangerous “forever chemicals” that contributed to cancer diagnoses. The consolidation ensures coordinated discovery and trial preparation across related PFAS claims.

https://www.aboutlawsuits.com/afff/firefighter-turnout-gear-lawsuits-belong-in-mdl-with-afff-pfas-exposure-lawsuits

3M PFAS Settlement Cases Advance Over Drinking Water Contamination

Cases tied to 3M’s multi-billion-dollar settlement over PFAS drinking water contamination are moving forward, including disputes over how funds will be distributed. Communities across Iowa and other states are pushing for greater accountability and remediation efforts. The settlement is one of the largest in U.S. environmental litigation history.

https://www.iowapublicradio.org/ipr-news/2025-08-25/pfas-forever-chemicals-drinking-water-contamination-settlement-cases-3m

DuPont Faces New Criticism Amid PFAS Settlement in New Jersey

Environmental advocates are highlighting gaps in DuPont’s $875 million settlement with New Jersey, arguing it fails to fully cover the long-term impact of PFAS pollution. Critics say more funds are needed to protect public health and restore contaminated ecosystems. The deal remains a landmark but has sparked debate over whether it goes far enough.

https://www.thecooldown.com/green-business/dupont-settlement-state-nj-pfas/

Depo-Provera

Pfizer Argues It Could Not Have Warned About Tumor Risk in Depo-Provera Lawsuits

Pfizer is seeking to dismiss claims in the Depo-Provera litigation, arguing it could not have warned about meningioma tumor risks because the scientific evidence was not available at the time. Plaintiffs counter that studies now clearly show increased risk, and that Pfizer downplayed safety concerns. The legal fight over what the company knew — and when — is central to the growing litigation.

https://www.reuters.com/legal/litigation/pfizer-says-it-couldnt-have-warned-about-tumor-risk-depo-provera-lawsuits-2025-08-25/

Over 1,000 Depo-Provera Brain Tumor Lawsuits Filed, 9,000 More Under Review

Court filings show that more than 1,000 lawsuits have already been filed over meningioma tumors allegedly caused by Depo-Provera, with another 9,000 potential cases under investigation. The litigation is expected to expand rapidly as more women link long-term use of the contraceptive to tumor diagnoses. Attorneys say the scale could rival other major pharmaceutical mass torts.

https://www.aboutlawsuits.com/depo-provera-lawsuit/1000-depo-provera-meningioma-lawsuits-filed-9000-under-investigation/

Sports Betting Addiction

DraftKings Pushes New Engagement Features as Addiction Lawsuits Mount

As lawsuits alleging gambling addiction gain traction, DraftKings has continued rolling out features designed to increase user engagement. Plaintiffs argue these tools encourage compulsive betting and worsen financial and psychological harm. The litigation raises broader questions about the responsibility of online gaming companies in preventing addiction.

https://www.aboutlawsuits.com/sports-betting-addiction-lawsuit/draftkings-pushes-additional-user-engagement-features-as-addiction-lawsuits-mount/

The Legal Calls Advantage - how we're different

• We know what really matters to you is the cost per compensable case.
• We conduct in-depth interviews by asking open-ended non-leading questions, like an attorney would do.
• Smart Reviews 3rd party case reviews are available.
• Full medical confirmation is available.

Click here to book a call

Craig H. Alinder, Vice President

Office: 802-664-4201 | Email: craig@legalcalls.com

LegalCalls.com | Calendly | Download our most recent price sheet

Legal Calls, 2108 N Street, Suite 4809, Sacramento, CA 95816, (877) 853-5801

‍